MedPath

SEIKAGAKU CORPORATION

πŸ‡―πŸ‡΅Japan
Ownership
-
Established
1947-01-01
Employees
-
Market Cap
-
Website
http://www.seikagaku.co.jp/

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

Phase 2
Completed
Conditions
Lumbar Vertebra Hernia
Interventions
Drug: Placebo
First Posted Date
2008-03-13
Last Posted Date
2023-03-23
Lead Sponsor
Seikagaku Corporation
Target Recruit Count
195
Registration Number
NCT00634946
Locations
πŸ‡―πŸ‡΅

Chubu Area, Chubu, Japan

πŸ‡―πŸ‡΅

Kansai Area, Kansai, Japan

πŸ‡―πŸ‡΅

Chugoku Area, Chugoku, Japan

and more 5 locations

Gel-200 Versus Placebo in Osteoarthritis of the Knee

Phase 3
Completed
Conditions
Osteoarthritis of the Knee
Interventions
Device: Gel-200
Device: Placebo
First Posted Date
2007-03-21
Last Posted Date
2011-10-07
Lead Sponsor
Seikagaku Corporation
Target Recruit Count
379
Registration Number
NCT00449696
Locations
πŸ‡ΊπŸ‡Έ

SKK, Plantation, Florida, United States

Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee

Phase 3
Completed
Conditions
Osteoarthritis of the Knee
First Posted Date
2007-03-21
Last Posted Date
2011-08-22
Lead Sponsor
Seikagaku Corporation
Target Recruit Count
202
Registration Number
NCT00450112
Locations
πŸ‡ΊπŸ‡Έ

SKK, Plantation, Florida, United States

Β© Copyright 2025. All Rights Reserved by MedPath